Florida Cannabis
Market Intelligence Report

Florida operates the largest medical-only cannabis market in the United States, serving 929,360 active qualified patients as of late May 2026 through a network of 766 dispensary locations run by 28 vertically-integrated Medical Marijuana Treatment Centers (MMTCs). The program, established by 2016's Amendment 2 and refined by subsequent legislation, reached an all-time sales peak of $2.185 billion in 2023.

Since that peak, the market's growth has clearly moderated: patient registry growth slowed from 11% in 2023 to roughly 3-4% annually in 2024 and 2025, as the program matures and competes with Florida's large unregulated hemp-derived THC market for the same consumer base. A November 2024 ballot measure to legalize adult-use cannabis (Amendment 3) won 56% of the vote — a clear majority, but short of the 60% supermajority Florida's constitution requires for a citizen initiative to pass — leaving the state medical-only for now. Meanwhile, a November 2025 federal spending bill provision redefining hemp products by total THC content (0.4mg or less) could sharply curtail the unregulated hemp competition that has weighed on medical cannabis demand, a development worth watching closely through 2026.

Florida's large, older-skewing population — the nation's third-most-populous state, with a median age above the national figure — helps explain its medical program's scale, with active patients now representing roughly 4% of all residents. (Official, Census ACS 2024)

The Florida Office of Medical Marijuana Use (OMMU), within the Department of Health, regulates the state's medical cannabis program. Under 2017 state law, the Department must issue four new MMTC licenses for every 100,000 additional patients added to the registry — a formula that, with nearly 930,000 patients now registered, should have triggered substantial license expansion. The Department announced 22 new license winners in late 2024, but legal challenges from unsuccessful applicants have stalled issuance, leaving the existing 28 MMTCs as the only active operators for now.

Florida does not operate a dedicated tax-incentive or grant program for cannabis businesses; the program's primary financial structure is its sales tax exemption for medical marijuana purchases.

Florida's cannabis supply chain runs through 28 vertically-integrated MMTCs that handle cultivation, processing, and dispensing under a single license — a structurally different model from states with separate cultivator, processor, and retailer license tiers. This vertical integration concentrates supply-chain control among a relatively small number of large operators, even as the 766-location retail footprint has continued to expand. The stalled 22-license expansion means no new vertically-integrated entrants have joined the supply base since the current cohort was licensed.

Florida's medical cannabis demand picture shows a market still growing in absolute patient and store count, but at a much slower pace than its early years — with unregulated hemp-derived THC products widely cited by industry trade press as a key factor pulling demand away from licensed dispensaries.

Florida's 766 dispensary locations are spread across all major metro areas statewide, with the largest concentrations in South Florida (Miami-Dade, Broward, Palm Beach), the Tampa Bay area, and Central Florida (Orlando metro), reflecting the state's population distribution. OMMU does not publish an official county-by-county dispensary count. (Not Available — county-level breakdown.)

Florida's vertically-integrated MMTC model concentrates costs very differently than tiered-license states — entry costs for the stalled 22 new licenses are substantially higher than a single dispensary buildout in most other state programs.

Vendor demand signal tracks which product and service categories Florida's MMTCs are actively sourcing this quarter.

Florida collects no sales tax or excise tax on medical marijuana purchases — a deliberate policy choice that keeps patient costs lower but means the state generates no direct tax revenue from its nearly $2.2 billion (at peak) medical cannabis market. As an illustrative reference only, applying the state's standard 6% sales tax to 2023's peak sales would have generated roughly $131 million; this is a modeled calculation, not an actual collected figure, since medical marijuana remains tax-exempt under current law.

Florida borders two states with far more restrictive cannabis programs than its own, limiting cross-border competitive pressure on the medical market.

OMMU does not publish a consolidated statewide cannabis-industry employment figure; given 28 vertically-integrated MMTCs operating 766 dispensary locations plus associated cultivation and processing facilities, total industry employment is likely in the thousands, though no official total is available. (Not Available.)

Florida's medical marijuana licensing law does not include a dedicated social equity license track; one of the 28 MMTC licenses is statutorily reserved for a Black Farmer License under the program's settlement framework. (Official.)

Florida does not publish an official illicit-market size estimate, but industry trade press widely cites the state's large unregulated hemp-derived THC product market — sold outside the licensed medical system — as a major competitive factor pulling demand away from licensed MMTCs. A November 2025 federal hemp redefinition (0.4mg total THC threshold) could substantially shrink this market if upheld. (Official as to existence; Not Available as to market size.)

This report blends official OMMU patient and licensing data, certified election results, and reputable cannabis industry trade press for sales trend analysis where OMMU does not publish a consolidated revenue figure.

This report compiles data from the Florida Office of Medical Marijuana Use, certified state election results, federal demographic sources, and reputable cannabis industry trade press.